Ceterix Orthopaedics, a Mountain View, California firm, landed FDA clearance for its new NovoStitch Plus meniscal repair device. Intended for repair, rather than the common meniscectomies, the device can allow surgeons to reach the meniscus from various angles to make repair easier to perform. Specifically, the system is used to place a circumferential compression stitch around the meniscus that can help maintain even pressure as the body heals the joint. Featuring a pre-loaded suture implant, the NovoStitch Plus more than halves the number of steps required to use the device compared to the original model.
“The NovoStitch Plus meniscal repair system represents a significant improvement to one of the most innovative technologies developed for knee procedures in many years,” said James Lee Pace, M.D., an orthopedic surgeon and director of the Sports Medicine Program at Children’s Hospital Los Angeles in a statement. “The NovoStitch device has allowed me to preserve the meniscus for many of my patients, significantly reducing their likelihood of arthritis or a total knee replacement later in life. I am looking forward to incorporating the new device into my practice.”
Source: Ceterix…